Indefinite Delivery Contract SPE2DR25D2022

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp as the prime contractor. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion across multiple regional awards. The IDC serves as a primary vehicle for DLA to efficiently procure essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. In addition, Amerisourcebergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The original solicitation, issued by DLA Troop Support Medical Supply Chain, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The solicitation is expected to be released in March 2024 and remain open for 45 days, with a vendor conference scheduled prior to the closing date. The procurement is fully competitive, with the intention to make multiple awards for separate regions to ensure resilience and access to vital pharmaceuticals during contingencies or natural disasters. Award will be made to responsive and responsible offerors whose proposals are technically acceptable and offer the lowest overall price based on distribution fees.